TherapeuticsMD (TXMD) Misses Q1 EPS by 1c

TherapeuticsMD (NASDAQ: TXMD) reported Q1 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $3.9 million versus the consensus estimate of $4.19 million.

For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• CVG to join Russell 2000 and Russell 3000 indexes June 26
• KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook